COVID-19 was first identified and breakout in the Chinese city Wuhan in early 2020, and glucocorticoids was one of the therapies for severe Covid-19 cases. What is the incident rate for glucocorticoids-induced osteonecrosis for Covid-19 patients? A systematic review of glucocorticoid associated osteonecrosis and an investigation of glucocorticoid exposure of COVID-19 patients in Wuhan city were conducted. The average of cumulative glucocorticoid (methylprednisolone) exposure was 504 mg for the Covid-19 patients and only 1 confirmed osteonecrosis case was identified out of 1406 patients with glucocorticoid treatment in this cohort of Wuhan patients, implying the importance of early prevention of glucocorticoids-induced osteonecrosis with patient screening and preventive measurements [1].
For challenging formal head osteonecrosis management, there are many new attempts published in recent 2 years in this Journal [[2], [3], [4], [5], [6], [7]]. In this issue Li et al. reported a novel scaffold carrying vascular bundle for the treatment of necrotic femoral head following decompression, they have also anastomosed the transplanted vascular bundles with the existing blood vessels around the hip, which significantly improved the treatment successful rate [8].
Continues understanding the mechanisms of bone repair will lead to novel and more efficient therapy. Journal of Orthopaedic Translation has published many innovative discoveries focusing on new technologies in the past 2 years [[9], [10], [11], [12], [13], [14], [15]]. In this issue, Wang et al. reported that transient activation of notch signaling by Jagged-1 peptide significantly enhanced mesenchymal stem cell proliferation in the bone marrow and promoted bone defect repair [16]. Of course, bone regeneration is closely associated with vascularization, therapeutic agents that stimulate angiogenesis will greatly benefit bone repair. When plant-derived Cucurbitacin B was incorporated into PLGA andβ-TCP scaffolds, they significantly enhanced neovascularization and bone formation in rat critical calvarial defect model [17].
Neve injury repair still remains as one of the most challenging orthopaedic issues. Clearance of myelin debris and remyelination are necessary steps for peripheral nerve regeneration, yet these processes are not well understood. Shi et al. screened the difference in genes of normal and activated Schwann cells harvested before and following peripheral nerve injury, and found that core genes in endocytosis pathway were highly activated following nerve injury, suggesting enhancing endocytosis may be a new therapeutic strategy for nerve tissue engineering [18].
Spinal cord injury (SCI) is a disastrous situation that affects many patients worldwide, yet the treatment options remain to be limited. Following the publication of clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019) in our journal in 2020 [19], we have published many original and cutting edge research work in SCI pathogenesis and treatment [[20], [21], [22]]. Among the many new targets, exosomes emerge to be a potential treatment option for SCI. Exosomes are complex lipid membrane structures secreted by cells, can transport their cargoes (proteins, microRNAs) to the targeted cells and exert their communication and regulation functions. Pan et al. have reviewed and discussed the use of various stem cells derived exosomes for the treatment of SCI [23].
Despite the long-lasting Covid-10 pandemic struggle, academics around the world are working tirelessly to provide education and service [24], discover new biological mechanisms in musculoskeletal tissue regeneration. New inventions continue to emerge to help building better bones and nerves. With combined endeavors, we shall overcome Covid-19 soon and be even stronger in body and mind!
References
- 1.Li Wenlong, Huang Zeqing, Tan Biao, Chen Gang, Li Xugui, Xiong Kan, et al. General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19. J Orthop Transl. 2021;31:1–9. doi: 10.1016/j.jot.2021.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Maruyama Masahiro, Pan Chi-Chun, Moeinzadeh Seyedsina, Storaci Hunter W., Guzman Roberto Alfonso, Lui Elaine, et al. Effect of porosity of a functionally-graded scaffold for the treatment of corticosteroid-associated osteonecrosis of the femoral head in rabbits. J Orthop Transl. 2021;28:90–99. doi: 10.1016/j.jot.2021.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhao Jun, Yue Tian, Lu Shibi, Meng Haoye, Lin Qiuxia, Ma Haiyang, et al. Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model. J Orthop Transl. 2021;27:132–138. doi: 10.1016/j.jot.2020.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Luo Yaping, Li Yingying, Hu Chunting, Wang Jinglong, Qin Ling, Fu Guohui, et al. Gastrin for prevention of steroid-associated osteonecrosis in rats. J Orthop Transl. 2020;25:105–114. [Google Scholar]
- 5.Huang Zeqing, Fu Fanyu, Ye Hengli, Gao Huanhuan, Tan Biao, Wang Rongtian, et al. Chinese herbal Huo-Gu Formula for treatment of steroid-associated osteonecrosis of femoral head: a 14-years follow-up of convalescent SARS patients. J Orthop Transl. 2020;23:122–131. doi: 10.1016/j.jot.2020.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhao Dewei, Zhang Feng, Wang Benjie, Liu Baoyi, Li Lu, Kim Shin-Yoon, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version) J Orthop Transl. 2020;21:100–110. doi: 10.1016/j.jot.2019.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wei Qiu-Shi, Hong Guo-Ju, Yuan Ying-Jia, Chen Zhen-Qiu, Zhang Qing-Wen, He Wei. Huo Xue Tong Luo capsule, a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head: a prospective study. J Orthop Transl. 2019;18:65–73. doi: 10.1016/j.jot.2018.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Li Bo, Yu Lingjia, Huang Zhenfei, Liang Yongxin, Li Guangping, Zhao Yu. A novel device for treatment of osteonecrosis of femoral head: feasibility and preliminary efficacy of animal study. J Orthop Transl. 2021;31:20–25. doi: 10.1016/j.jot.2021.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Yang Chengyuan, Gao Cheng, Liu Naicheng, Zhu Yitong, Zhu Xu, Su Xinlin, et al. The effect of traumatic brain injury on bone healing from a novel exosome centered perspective in a mice model. J Orthop Transl. 2021;30:70–81. doi: 10.1016/j.jot.2021.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Li Meng Chen Michelle, Chow Simon Kwoon Ho, Wong Ronald Man Yeung, Qin Ling, Cheung Wing Hoi. The role of osteocytes-specific molecular mechanism in regulation of mechanotransduction – a systematic review. J Orthop Transl. 2021;29:1–9. doi: 10.1016/j.jot.2021.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kang Yang-Jae, Yoo Jun-Il, Baek Kyung-Wan. Differential gene expression profile by RNA sequencing study of elderly osteoporotic hip fracture patients with sarcopenia. J Orthop Transl. 2021;29:10–18. doi: 10.1016/j.jot.2021.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dreyer Timothy, Shah Mittal, Doyle Carl, Greenslade Kevin, Penney Mark, Creeke Paul, et al. Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis. J Orthop Transl. 2021;29:134–142. doi: 10.1016/j.jot.2021.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dang Lei, Zhu Jinglin, Song Chunli. The effect of topical administration of simvastatin on entochondrostosis and intramembranous ossification: an animal experiment. J Orthop Transl. 2021;28:1–9. doi: 10.1016/j.jot.2020.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhu Junlang, Liu Yamei, Chen Chen, Chen Hongtai, Huang Jiewen, Luo Yiwen, et al. Cyasterone accelerates fracture healing by promoting MSCs migration and osteogenesis. J Orthop Transl. 2021;28:28–38. doi: 10.1016/j.jot.2020.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hou Yonghui, Lin Weiping, Li Ying, Sun Yuxin, Liu Yamei, Chen Chen, et al. De-osteogenic-differentiated mesenchymal stem cells accelerate fracture healing by mir-92b. J Orthop Transl. 2021;27:25–32. doi: 10.1016/j.jot.2020.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wang Guangxi, Yan Jinglong, Zhang Hao, Massey Patrick, Alexander J. Steven, Kevil Christopher G., et al. Transient activation of notch signaling enhances endogenous stromal cell expansion and subsequent bone defect repair. J Orthop Transl. 2021;31:26–32. doi: 10.1016/j.jot.2021.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cheng Wen-Xiang, Liu Yan-Zhi, Meng Xiang-Bo, Zheng Zheng-Tan, Li Ling-Li, Ke Li-Qing, et al. PLGA/β-TCP composite scaffold incorporating cucurbitacin B promotes bone regeneration by inducing angiogenesis. J Orthop Transl. 2021;31:41–51. doi: 10.1016/j.jot.2021.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Shi Guidong, Hao Dingyu, Zhang Lei, Qin Jia, Tian Guangyuan, Ma Boyuan, et al. Endocytosis-associated patterns in nerve regeneration after peripheral nerve injury. J Orthop Transl. 2021;31:10–19. doi: 10.1016/j.jot.2021.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Huang Hongyun, Young Wise, Skaper Stephen, Chen Lin, Moviglia Gustavo, Saberi Hooshang, et al. Clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019) J Orthop Transl. 2020;20:14–24. doi: 10.1016/j.jot.2019.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Peng Peng, Yu Hao, Li Yongjin, Huang Jingyuan, Yao Shengyu, Xing Cong, et al. The emerging role of circular RNAs in spinal cord injury. J Orthop Transl. 2021;30:1–5. doi: 10.1016/j.jot.2021.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wu Xiuhua, Xu Xiaolin, Liu Qi, Ding Jianyang, Liu Junhao, Huang Zhiping, et al. Unilateral cervical spinal cord injury induces bone loss and metabolic changes in non-human primates (Macaca fascicularis) J Orthop Transl. 2021;29:113–122. doi: 10.1016/j.jot.2021.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yao Xue, Sun Chao, Fan Baoyou, Zhao Chenxi, Zhang Yan, Duan Huiquan, et al. Neurotropin exerts neuroprotective effects after spinal cord injury by inhibiting apoptosis and modulating cytokines. J Orthop Transl. 2021;26:74–83. doi: 10.1016/j.jot.2020.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pan Dayu, Liu Weixiao, Zhu Shibo, Fan Baoyou, Yu Nanxi, Ning Guangzhi, et al. Potential of different cells-derived exosomal microRNA cargos for treating spinal cord injury. J Orthop Transl. 2021;31:33–40. doi: 10.1016/j.jot.2021.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ong Michael Tim-Yun, Ling Samuel Ka-Kin, Wong Ronald Man-Yeung, Ho Kevin Ki-Wai, Chow Simon Kwoon-Ho, Cheung Louis Wing-Hoi, et al. Impact of COVID-19 on orthopaedic clinical service, education and research in a university hospital. J Orthop Transl. 2020;25:125–127. doi: 10.1016/j.jot.2020.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]